DoD Tuberous Sclerosis Complex, Clinical Translational Research Award


Funding Opportunity ID: 313075
Opportunity Number: W81XWH-19-TSCRP-CTRA
Opportunity Title: DoD Tuberous Sclerosis Complex, Clinical Translational Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: Feb 19, 2019
Close Date: May 09, 2019
Last Updated Date: Feb 19, 2019
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $1,920,000
Expected Number of Awards: 2
Description: The Clinical Translational Research Award supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of TSC. Projects supported by this award mechanism may include studies moving from preclinical to clinical research (including a pilot clinical trial) and/or the reverse, analyzing human anatomical substances and/or data associated with clinical trials (such as correlative studies). Studies advancing clinical trial readiness through development of biomarkers, clinical endpoints, and validation of PK/PD are of particular interest to the FY19 TSCRP. Preference will be given to studies that involve human samples, patients, or leverage existing clinical data and/or ongoing clinical studies. Preclinical studies may be appropriate but must include a clinical component. Projects that are exploratory and/or strictly animal research will not be considered for funding. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism can be found in the report of the National Cancer Institute Translational Research Working Group ( content/14/18/5664.full). These pathways are comprehensive and span the entire translational research continuum from bench to bedside to bench.
Version: 1

Visit the Official Webpage For More Details on DoD Tuberous Sclerosis Complex, Clinical Translational Research Award


Please enter your comment!
Please enter your name here